106 related articles for article (PubMed ID: 8108124)
1. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions.
Walker GJ; Palmer JM; Walters MK; Nancarrow DJ; Parsons PG; Hayward NK
Oncogene; 1994 Mar; 9(3):819-24. PubMed ID: 8108124
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
[TBL] [Abstract][Full Text] [Related]
5. Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer.
Mead LJ; Gillespie MT; Irving LB; Campbell LJ
Cancer Res; 1994 May; 54(9):2307-9. PubMed ID: 8162570
[TBL] [Abstract][Full Text] [Related]
6. Haplotype analysis limits the position of the familial melanoma locus on 9p to the D9S169-D9S156 interval.
Walker GJ; Nancarrow DJ; Palmer JM; Walters MK; Hayward NK
Melanoma Res; 1994 Feb; 4(1):29-34. PubMed ID: 8032215
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
[TBL] [Abstract][Full Text] [Related]
8. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
[TBL] [Abstract][Full Text] [Related]
9. Melanoma ex naevo: a study of the associated naevus.
Bogdan I; Smolle J; Kerl H; Burg G; Böni R
Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A/p16 is inactivated in most melanoma cell lines.
Castellano M; Pollock PM; Walters MK; Sparrow LE; Down LM; Gabrielli BG; Parsons PG; Hayward NK
Cancer Res; 1997 Nov; 57(21):4868-75. PubMed ID: 9354451
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
12. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group.
James CD; He J; Collins VP; Allalunis-Turner MJ; Day RS
Cancer Res; 1993 Aug; 53(16):3674-6. PubMed ID: 8339274
[TBL] [Abstract][Full Text] [Related]
13. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
Kamb A; Shattuck-Eidens D; Eeles R; Liu Q; Gruis NA; Ding W; Hussey C; Tran T; Miki Y; Weaver-Feldhaus J
Nat Genet; 1994 Sep; 8(1):23-6. PubMed ID: 7987388
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA.
Devlin J; Keen AJ; Knowles MA
Oncogene; 1994 Sep; 9(9):2757-60. PubMed ID: 8058343
[TBL] [Abstract][Full Text] [Related]
16. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
17. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
Huang DP; Lo KW; van Hasselt CA; Woo JK; Choi PH; Leung SF; Cheung ST; Cairns P; Sidransky D; Lee JC
Cancer Res; 1994 Aug; 54(15):4003-6. PubMed ID: 8033130
[TBL] [Abstract][Full Text] [Related]
18. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
19. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
[TBL] [Abstract][Full Text] [Related]
20. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]